DNPUF News and Press, Dai Nippon Pharm Ord

2024-04-25 10:05:00 ET Summary Tourlite Capital Management, LP is an asset management firm focused on long/short equity investing in public companies. Tourlite Fund, LP returned 6.0% for the First Quarter of 2024. The Fund has annualized returns of 10.0% since inception, compa...

2023-12-22 17:56:28 ET Summary The biotech bear market has presented investment opportunities for investors to take meaningful stakes in public companies at venture valuations. AI drug discovery has faced setbacks in the past 18 months, but Gain Therapeutics' has found success usi...

Myovant Sciences ( NYSE: MYOV ) has cancelled its Q2 earnings call , scheduled for Oct. 26, due to the buyout of the women's health company by Sumitovant Biopharma. Earlier Monday, Sumitovant, a unit of Sumitovo Pharma ( OTCPK:DNPUF ), said it would acquire the t...

Nabriva Therapeutics (NBRV) and Sinovant Sciences' antibiotic lefamulin was non-inferior to moxifloxacin in a phase 3 study, according to top-line results.The randomized, double-blind study in 125 patients with community acquired bacterial pneumonia compared the efficacy and safety of IV/oral...

Sumitomo Dainippon Pharma ( OTCPK:DNPUF ) extends additional $200M low-interest, five-year term loan to Myovant Sciences (NYSE: MYOV ) , bringing its total financing support to $600M. More news on: Sumitomo Dainippon Pharma Co., Ltd., Myovant Sciences Ltd., Healthcare stocks n...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

Kyoto, Japan, June 25, 2019 - (JCN Newswire) - Hacarus Inc, the leading provider of lightweight and explainable AI, was today awarded the Grand Prize by DS Pharma Animal Health for its innovative AI-enabled technology platform 'HACARUS.ai'. "It is a great honor to receive this award for our w...

ADHD Treatment Is a Crowded Space ADHD is a common disorder impacting approximately 11% of children, 8.7% of adolescents, and 4.4% of adults according to the NIMH . For background on the disorder, I recommend reading the following articles on Seeking Alpha: Agamemnus on "What is ADHD?"...